These factors could provide a scientific basis for consistency evaluations of the quality and efficacy of insulin biosimilars, study authors wrote. Factors that may affect the bioequivalence of test ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel ...
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Zacks Investment Research on MSN
HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal
Shares of Harmony Biosciences Holdings, Inc. HRMY lost 16.56% on Sept. 24 after the company announced the failure of the late ...
Please provide your email address to receive an email when new articles are posted on . Alpha Cognition Inc. has announced positive results from a bioequivalence study with Alpha-1062, a proprietary, ...
Bioequivalence studies are an essential component in the development and approval of generic pharmaceutical products, ensuring that they perform similarly to their reference counterparts. These ...
ET-600 matched the pharmacokinetics of the FDA-approved reference product in a study with 75 subjects. Eton expects to submit an NDA for ET-600 in April 2025, targeting a 2026 launch. Today's manic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback